Faculty

Institution

Unit

Venue

Khaled Sanber

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Head And Neck Surgery

Department Of Head And Neck Surgery, Section Of Speech Pathology And Audiology

Department Of Thoracic-Head And Neck Med Onc

The University of Texas MD Anderson Cancer Center

NoneKhaled Sanber is currently serving as a Head And Neck Surgery faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Khaled Sanber

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

immunology cancer immunotherapy cancer research oncology cellular therapy cancer cells cancer biology tumor biology lung cancer t-regulatory cell molecular biology immune responses oncogenes cell transplantation immune checkpoint inhibitors thoracic oncology brain tumor research cancer treatment cancer immunosurveillance tumor suppressors medicinal research vascular biology cell therapy medicine cell signaling clinical investigation medical virology signaling pathways immunoediting cellular immune responses immunologic outcomes bipartite activation checkpoint reversal receptor a phase 1/2 advanced sarcoma dermatology therapeutic targets leukemia cancer discovery cell research stem cell research cancer care general virology hematological malignancies maternal immunization adaptive immune system host factors tumor targeting heme signaling trace metals disease progression immunomodulation inhibitory activity single-cell analysis transcriptomics technology single cell sequencing gene editing crispr neck oncology cancer growth viral oncology cancer management cancer genomics cancer-associated virus oral cancer car t-cells tumor response endogenous immune reactivity metastatic rhabdomyosarcoma hydrogen sulphide advanced sarcomas neoadjuvant immunotherapy autologous tumor phase 1 antitumor function mesenchymal-epithelial transition factor

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 49: The Per3-Rorb Axis Defines a Tumor-Suppressive Circadian State Associated With Improved Survival in Head and Neck Squamous Cell Carcinoma.. Cancer Research (2026)

oncogenesradiation oncologytumor-suppressive circadian statetumor biologyper3-rorb axiscell biologyneck oncologycancer researchtumor suppressorscancer growthcancer cellsabstract 49oncologycancer biology

569 a Phase 1/2 Study of Ksq-004Ex: Autologous Tumor Infiltrating Lymphocytes, Engineered to Inactivate Genes Encoding Socs1 and Regnase-1, in Patients With Select Advanced Solid Tumors. Regular and Young Investigator Award Abstracts (2025)

oncogenesautologous tumorcancer immunotherapyimmunologycell biologycellular therapya phase 1/2cancer immunosurveillancecancer cellscell researchimmunoeditingtumor microenvironment

A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances Car T-Cell Function. Cancer Research Communications (2025)

Daniel LandiShoba A. NavaiRebecca M. BrockKristen FousekZeid NawasKhaled SanberCynthia Chauvin-FleurenceRaksha R. BhatShuo XuPurna KrishnamurthyMichelle ChoeMatthew CampbellJessica S. MorrisAhmed Z. GadAnkita ShreeAlesandra EcheandiaAmr SaadeldinPretty R. MatthewDolores MullikinKevin BielamowiczLyazat KurenbekovaAngela M. MajorVita S. SalsmanTiara T. ByrdM. John HicksYi Jonathan. ZhangJason YusteinAlexandre F. CariseySujith K. JosephNabil AhmedMeenakshi Hegde

bipartite activationt-regulatory cellcancer immunotherapyimmunologycancer researchimmune responsesmolecular biologycheckpoint reversal receptorsystems biologycancer treatmentreceptorsimmune checkpoint inhibitorsoncologycancer biology

Supplementary Figure 7 From a Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances Car T-Cell Function. (2025)

Daniel LandiShoba A. NavaiRebecca M. BrockKristen FousekZeid NawasKhaled SanberCynthia Chauvin-FleurenceRaksha R. BhatShuo XuPurna KrishnamurthyMichelle ChoeMatthew E. CampbellJessica S. MorrisAhmed Z. GadAnkita ShreeAlesandra S. Echeandia MarreroAmr M. SaadeldinPretty R. MatthewDolores MullikinKevin BielamowiczLyazat KurenbekovaAngela M. MajorVita S. SalsmanTiara T. ByrdJohn M. HicksYi Jonathan ZhangJason YusteinAlexandre F. CariseySujith K. JosephNabil AhmedMeenakshi Hegde

bipartite activationt-regulatory cellimmunologyimmune responsesmolecular biologycheckpoint reversal receptorreceptors

Supplementary Tables 1 From Divergent Clinical and Immunologic Outcomes Based on I Stk11 /I Co-Mutation Status in Resectable I Kras- /I Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade. (2025)

Samuel RosnerSydney ConnorKhaled SanberMarianna ZahurakTianbei ZhangIsha GurumurthyZhen ZengBrad PressonDipika SinghRoni RayesLavanya SivapalanGavin PereiraZhicheng JiRohit ThummalapalliJoshua E. ReussStephen R. BroderickDavid R. JonesJulie S. DeutschTricia R. CottrellJamie E. ChaftJonathan SpicerJanis TaubeValsamo AnagnostouJulie R. BrahmerDrew M. PardollHongkai JiPatrick M. FordeKristen A. MarroneKellie N. Smith

immunologic outcomesimmunologyimmune checkpoint inhibitorslung cancer

660 a Phase 1/2 Study of Ksq-001Ex: An Autologous Tumor-Infiltrating Lymphocyte Therapy Engineered to Inactivate the Socs1 Gene in Patients With Select Advanced Solid Tumors. Regular and Young Investigator Award Abstracts (2024)

cancer immunotherapyimmunologycell biologycell transplantationimmunotherapycellular therapyimmunoeditinga phase 1/2cancer immunosurveillancecancer cellsimmune checkpoint inhibitorstumor microenvironment

878 the Immunomodulatory Impact of Chemotherapy When Combined With Pd-1 Blockade in Resectable Lung Cancers. Regular and Young Investigator Award Abstracts (2024)

Sydney C ConnorJiajia ZhangKhaled SanberTianbei ZhangRoni RayesRulin WangZhicheng JiIsha GurumurthyDipika SinghJulie S DeutschJanis M TaubeSrinivasan YegnasubramanianJonathan SpicerPatrick FordeHongkai JiDrew M PardollKellie N Smith

immunologyclinical investigationlung cancerimmunomodulatory impactcancer treatmentresectable lung cancersoncology

Abstract B047: Predictive Molecular Signatures of Tumor Reactivity From Antigen Specific Tumor Infiltrating Lymphocytes (Tils) in Human Papillomavirus (Hpv)-Positive Oropharyngeal Carcinoma (Opc). Cancer Immunology Research (2024)

pathologytumor biologyvirologycancer-associated virustumor reactivityimmunologycell biologyabstract b047oral cancerpredictive molecular signaturescancer immunosurveillancemedical virologygeneral virologycancer lettertumor microenvironment

Autologous Her2-Specific Car T Cells After Lymphodepletion for Advanced Sarcoma: A Phase 1 Trial. UNC Libraries (2024)

phase 1cell therapycancer immunotherapysarcomaimmunologycell biologycell transplantationimmunotherapycellular therapyimmunomodulationimmune responsescellular immune responsesadvanced sarcoma

Divergent Clinical and Immunologic Outcomes Based on Stk11 Co-Mutation Status in Resectable Kras- Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade. Clinical Cancer Research (2024)

Samuel RosnerSydney ConnorKhaled SanberMarianna ZahurakTianbei ZhangIsha GurumurthyZhen ZengBrad PressonDipika SinghRoni RayesLavanya SivapalanGavin PereiraZhicheng JiRohit ThummalapalliJoshua E. ReussStephen R. BroderickDavid R. JonesJulie S. DeutschTricia R. CottrellJamie ChaftJonathan SpicerJanis TaubeValsamo AnagnostouJulie R. BrahmerDrew M. PardollHongkai JiPatrick M. FordeKristen A. MarroneKellie N. Smith

immunologic outcomesimmunologydisease progressionclinical investigationlung cancercancer researchclinical research

1
2
3
10 / page

Khaled Sanber

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Head And Neck Surgery

Department Of Head And Neck Surgery, Section Of Speech Pathology And Audiology

Department Of Thoracic-Head And Neck Med Onc

The University of Texas MD Anderson Cancer Center

NoneKhaled Sanber is currently serving as a Head And Neck Surgery faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Khaled Sanber

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 49: The Per3-Rorb Axis Defines a Tumor-Suppressive Circadian State Associated With Improved Survival in Head and Neck Squamous Cell Carcinoma.. Cancer Research (2026)

oncogenesautologous tumorcancer immunotherapyimmunologycell biologycellular therapya phase 1/2cancer immunosurveillancecancer cellscell researchimmunoeditingtumor microenvironment

A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances Car T-Cell Function. Cancer Research Communications (2025)

Supplementary Figure 7 From a Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances Car T-Cell Function. (2025)

Daniel LandiShoba A. NavaiRebecca M. BrockKristen FousekZeid NawasKhaled SanberCynthia Chauvin-FleurenceRaksha R. BhatShuo XuPurna KrishnamurthyMichelle ChoeMatthew E. CampbellJessica S. MorrisAhmed Z. GadAnkita ShreeAlesandra S. Echeandia MarreroAmr M. SaadeldinPretty R. MatthewDolores MullikinKevin BielamowiczLyazat KurenbekovaAngela M. MajorVita S. SalsmanTiara T. ByrdJohn M. HicksYi Jonathan ZhangJason YusteinAlexandre F. CariseySujith K. JosephNabil AhmedMeenakshi Hegde

bipartite activationt-regulatory cellimmunologyimmune responsesmolecular biologycheckpoint reversal receptorreceptors

immunologic outcomesimmunologyimmune checkpoint inhibitorslung cancer

878 the Immunomodulatory Impact of Chemotherapy When Combined With Pd-1 Blockade in Resectable Lung Cancers. Regular and Young Investigator Award Abstracts (2024)

immunologyclinical investigationlung cancerimmunomodulatory impactcancer treatmentresectable lung cancersoncology

Autologous Her2-Specific Car T Cells After Lymphodepletion for Advanced Sarcoma: A Phase 1 Trial. UNC Libraries (2024)

phase 1cell therapycancer immunotherapysarcomaimmunologycell biologycell transplantationimmunotherapycellular therapyimmunomodulationimmune responsescellular immune responsesadvanced sarcoma

Samuel RosnerSydney ConnorKhaled SanberMarianna ZahurakTianbei ZhangIsha GurumurthyZhen ZengBrad PressonDipika SinghRoni RayesLavanya SivapalanGavin PereiraZhicheng JiRohit ThummalapalliJoshua E. ReussStephen R. BroderickDavid R. JonesJulie S. DeutschTricia R. CottrellJamie ChaftJonathan SpicerJanis TaubeValsamo AnagnostouJulie R. BrahmerDrew M. PardollHongkai JiPatrick M. FordeKristen A. MarroneKellie N. Smith

immunologic outcomesimmunologydisease progressionclinical investigationlung cancercancer researchclinical research

1
2
3
10 / page